These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 7594322

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
    Suzuki M, Kitahora T, Nagahashi S, Suzuki H, Mori M, Hibi T, Ishii H.
    J Clin Gastroenterol; 1998 Mar; 27 Suppl 1():S183-6. PubMed ID: 9872519
    [Abstract] [Full Text] [Related]

  • 25. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
    Lamouliatte H, Cayla R, Zerbib F, Forestier S, de Mascarel A, Joubert-Collin M, Mégraud F.
    Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
    [Abstract] [Full Text] [Related]

  • 26. Clinical efficacy of lansoprazole-amoxicillin treatment in eradicating Helicobacter pylori: evaluation by the polymerase chain reaction method.
    Shimada T, Ogura K, Ota S, Terano A.
    J Clin Gastroenterol; 1995 Sep; 20 Suppl 2():S100-3. PubMed ID: 7594321
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer.
    Suzuki J, Mine T, Kobayasi I, Fujita T.
    J Clin Gastroenterol; 1998 Sep; 27 Suppl 1():S159-62. PubMed ID: 9872515
    [Abstract] [Full Text] [Related]

  • 30. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori.
    Fennerty MB, Kovacs TO, Krause R, Haber M, Weissfeld A, Siepman N, Rose P.
    Arch Intern Med; 1998 Sep; 158(15):1651-6. PubMed ID: 9701099
    [Abstract] [Full Text] [Related]

  • 31. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA, Van Rensburg CJ, Moola S, Kotze D, Marks IN.
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Erradicating treatment of Helicobacter pylori with lansoprazole and amoxicillin in duodenal ulcer patients].
    Gisbert JP, Boixeda D, Alvarez Baleriola I, Martín de Argila C, Bermejo F, Aller R.
    Rev Clin Esp; 1996 Sep; 196(9):588-93. PubMed ID: 8966319
    [Abstract] [Full Text] [Related]

  • 34. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
    Maconi G, Russo A, Imbesi V, Cucino C, Bianchi Porro G.
    Dig Liver Dis; 2000 May; 32(4):275-80. PubMed ID: 11515622
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H, Perie F, Joubert-Collin M.
    Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
    [Abstract] [Full Text] [Related]

  • 36. Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients.
    Parente F, Maconi G, Bargiggia S, Colombo E, Bianchi Porro G.
    Aliment Pharmacol Ther; 1996 Apr; 10(2):211-3. PubMed ID: 8730253
    [Abstract] [Full Text] [Related]

  • 37. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
    Lai YC, Wang TH, Huang SH, Yang SS, Wu CH, Chen TK, Lee CL.
    World J Gastroenterol; 2003 Jul; 9(7):1537-40. PubMed ID: 12854158
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
    Murakami M, Saita H, Takahashi Y, Kusaka S, Asagoe K, Dekigai H, Matsumoto M, Seki M, Mizuno M, Maeda S.
    J Clin Gastroenterol; 1995 Jul; 20 Suppl 2():S79-82. PubMed ID: 7594348
    [Abstract] [Full Text] [Related]

  • 39. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
    Hepatogastroenterology; 1998 Jul; 45(22):990-3. PubMed ID: 9755995
    [Abstract] [Full Text] [Related]

  • 40. Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole in clinical studies.
    Lamouliatte H.
    J Clin Gastroenterol; 1995 Jul; 20 Suppl 1():S28-31. PubMed ID: 7673611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.